Hager Biosciences, LLC logo — Source of Innovative Preclinical Therapeutic Leads for partn...

Hager Biosciences, LLC

Source of Innovative Preclinical Therapeutic Leads for partnering or full out-licensing & IP assignment

United States Bethlehem, United States 8 employees Biotechnology, Health Care +2

General Information

Company Name Hager Biosciences, LLC
Location United States Bethlehem, United States +1
Employees 8
Industries Biotechnology, Health Care, Health and Wellness +1
Social

Get notified when Hager Biosciences, LLC moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hager Biosciences, LLC

is a preclinical-stage organization specializing in innovative discovery medicinal chemistry. The company's mission is to become a preferred partner to pharmaceutical and biotech firms by providing through out-licensing for unmet medical needs. Key to their business model is the capability to design and synthesize proprietary small for modular adaptation into new or existing drug candidate optimization or novelization projects. Its discovery provides a competitive and efficient advantage for rapid novel lead generation, optimization, and drug rescue. Hager's highly cost-effective and efficient discovery research process, including using outsourced network infrastructures, has a solid track record of innovative preclinical pharmaceutical candidate discovery in , attested by several generated. Recent examples of awarded as well as filed from which two clinical candidates are on the verge of entering for include: 11,505,555 10,329,301 11,414,425 10,815,242 11,142,529 11,312,721 16/445,854 63/399,509 WO2020247447 WO2020247445 US2022/0259224 63/403,019 63/400,894

Taxonomy: Preclinical drug discovery, Therapeutic leads, Medicinal chemistry, Out-licensing, IP assignment, FragPhore platform, CNS therapeutics, Alzheimer's disease, Infectious diseases, Metabolic disorders, Neuropathic pain, Substance abuse, Drug design, Multi-targeted drug discovery

No funding data available for Hager Biosciences, LLC yet.

Get notified when Hager Biosciences, LLC raises funding

Hager Biosciences, LLC Alternatives & Competitors

Hager Biosciences, LLC vs

Designing Higher-⁠Quality Medicines with Next⁠-⁠Generation Computational Drug Discovery

Hager Biosciences, LLC vs

Our Science for Your Science

12 employees
Manufacturing, Pharmaceutical
Hager Biosciences, LLC vs
Melior Discovery
Melior Discovery United States

Capture the Untapped Value of Therapeutics

Series Unknown
29 employees
Biopharma, Biotechnology

FAQ About Hager Biosciences, LLC

Source of Innovative Preclinical Therapeutic Leads for partnering or full out-licensing & IP assignment
Hager Biosciences, LLC is headquartered in Bethlehem, United States.
Hager Biosciences, LLC operates in the following industries: Biotechnology, Health Care, Health and Wellness, Pharmaceutical.
Hager Biosciences, LLC has approximately 8 employees.
Top alternatives and competitors to Hager Biosciences, LLC include Pending AI, Genesis Drug Discovery & Development (GD³), Melior Discovery, FAR Biotech, Modulus Discovery. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hager Biosciences, LLC and Pending AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hager Biosciences, LLC and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes